We've found
184,457
clinical trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Lung Cancer
Status: Enrolling,
Phase
II
Updated: 4/21/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatosplenic T-cell Lymphoma Clinical Trial
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
Status: Enrolling,
Phase
I
Updated: 2/1/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
Status: Enrolling,
Phase
I
Updated: 2/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
Status: Enrolling
Updated: 7/10/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
Status: Enrolling
Updated: 7/10/2012
Click here to add this to my saved trials
Atypical Hemolytic-Uremic Syndrome Clinical Trial
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Clinical Trial
ANCHOR (Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Clinical Trial
ANCHOR (Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
We've found
184,457
clinical trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 4/21/2014
A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Lung Cancer
Status: Enrolling,
Phase
II
Updated: 4/21/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Updated: 12/31/1969
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatosplenic T-cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
Updated: 11/14/2012
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
Updated: 11/14/2012
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
Updated: 11/14/2012
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
Updated: 11/14/2012
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
Updated: 11/14/2012
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
Updated: 11/14/2012
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Updated: 2/1/2016
BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
Status: Enrolling,
Phase
I
Updated: 2/1/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Updated: 2/1/2016
BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
Status: Enrolling,
Phase
I
Updated: 2/1/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 7/10/2012
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
Status: Enrolling
Updated: 7/10/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 7/10/2012
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
Status: Enrolling
Updated: 7/10/2012
Click here to add this to my saved trials
Atypical Hemolytic-Uremic Syndrome Clinical Trial
Updated: 12/31/1969
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Clinical Trial
Updated: 12/31/1969
ANCHOR (Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Clinical Trial
Updated: 12/31/1969
ANCHOR (Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials